Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine
Mônica R. Gadelha, Alessandra Casagrande, Christian J. Strasburger, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 110, Iss. 1, pp. 228-237
Open Access | Times Cited: 14

Showing 14 citing articles:

Differential Impact of Medical Therapies for Acromegaly on Glucose Metabolism
Federico Gatto, Anna Arecco, Jessica Amarù, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 465-465
Open Access | Times Cited: 1
Octreotide subcutaneous depot for acromegaly: A randomized, double-blind, placebo-controlled phase 3 trial, ACROINNOVA 1
Diego Ferone, Pamela U. Freda, Laurence Katznelson, et al.
The Journal of Clinical Endocrinology & Metabolism (2024)
Open Access | Times Cited: 5
Impact of strict IGF1 control on quality-of-life scores in patients with acromegaly
Chaitanya Gandhi, Marie-Claire Denis, Daniel T. Holmes, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
New drugs in pituitary diseases
Fernando Cordido, Pedro Iglesias
Endocrinología Diabetes y Nutrición (2025), pp. 501546-501546
Closed Access
Promising therapies for the treatment of acromegaly
Sylvère Störmann, Katharina Schilbach
Expert Opinion on Pharmacotherapy (2025)
Closed Access
Oral paltusotine, a nonpeptide selective somatostatin receptor 2 agonist: Mass balance, absolute bioavailability and metabolism in healthy participants
Rosa Luo, Ajay Madan, Christine Ferrara-Cook, et al.
British Journal of Clinical Pharmacology (2025)
Open Access
New drugs in pituitary diseases
Fernando Cordido, Pedro Iglesias
Endocrinología Diabetes y Nutrición (English ed ) (2025) Vol. 72, Iss. 3, pp. 501546-501546
Closed Access
The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectives
E Lauricella, Sofija Vilisova, Nada Chaoul, et al.
Expert Review of Neurotherapeutics (2024), pp. 1-14
Closed Access | Times Cited: 1
Paltusotine: A Step Towards Precision Medicine in Acromegaly
Fréderic Castinetti, Thierry Brue
The Journal of Clinical Endocrinology & Metabolism (2024)
Open Access
Advances in the Oral Administration of Somatostatin Receptor Ligands in Acromegaly: A Systematic Review Focusing on Biochemical Response
Clémence Reverdiau, Damien Denimal
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1357-1357
Open Access
Medical therapy of pituitary adenomas
Mark E. Molitch
Brain medicine : (2024), pp. 1-9
Closed Access
Pharmacological management of pituitary adenomas – what is new on the horizon?
Elena V. Varlamov, Monica Livia Gheorghiu, Maria Fleseriu
Expert Opinion on Pharmacotherapy (2024)
Open Access
Are Oral Somatostatin Receptor Ligands Moving Closer to Becoming a Reality?
David S. McLaren, Nikolaos Kyriakakis, Khyatisha Seejore, et al.
Clinical Endocrinology (2024) Vol. 102, Iss. 3, pp. 288-290
Closed Access
Acromegaly: Pitfalls in diagnosis and treatment
Mirjana Doknić
Galenika Medical Journal (2024) Vol. 3, Iss. 12, pp. 28-40
Closed Access
Page 1

Scroll to top